INTERSTITIAL LUNG DISEASES
Clinical trials for INTERSTITIAL LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASES trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks nintedanib's long-term effects on scleroderma lung disease
Disease control OngoingThis study follows 2,000 people with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who are taking nintedanib. Researchers want to see how the drug affects lung function, quality of life, and survival over time. Participants are already part of the EUSTAR regis…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Lung cancer and scarred lungs: a new study seeks answers
Knowledge-focused OngoingThis study looks at 200 people with both lung cancer and a lung scarring condition called pulmonary fibrosis. Researchers want to see how well immunotherapy (a type of cancer treatment) works in these patients and if it causes more side effects. They will also study tumor samples…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 09:34 UTC